Emtricitabine
FDA Approved: * March 15, 2023Pharm Company: * AUROBINDO PHARMA
Category: HIV / AIDS
Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine[1]), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse-transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. Emtricitabine is also marketed in a fixed-dose combination with tenofovir disoproxil (Viread) under the brand name Truvada, and with tenofovir alafenamide (Vemlidy) under the brand name Descovy. A fixed-dose tr... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.